Propagation, Inactivation, and Safety Testing of SARS-CoV-2

In late 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, the capital of the Chinese province Hubei. Since then, SARS-CoV-2 has been responsible for a worldwide pandemic resulting in over 4 million infections and over 250,000 deaths. The pandem...

Full description

Saved in:

Bibliographic Details
Published in:	Viruses Vol. 12; no. 6; p. 622
Main Authors:	Jureka, Alexander, Silvas, Jesus, Basler, Christopher
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 06.06.2020 MDPI
Subjects:	agarose Animals Betacoronavirus - drug effects Betacoronavirus - growth & development Betacoronavirus - pathogenicity Betacoronavirus - physiology biosafety Cell lines Cellulose China Chlorocebus aethiops Coronaviridae coronavirus Coronavirus Infections - virology Coronaviruses COVID-19 COVID-19 infection Culture Media - chemistry DNA Formaldehyde formalin Gene expression Genomes Guanidines - pharmacology Heat HEK293 Cells Humans inactivation Infections Infectivity lactones pandemic Pandemics pathogenicity Phenols - pharmacology Plaque assay Pneumonia, Viral - virology Propagation Propiolactone - pharmacology Ribonucleic acid RNA safety testing SARS-CoV-2 Sepharose Severe acute respiratory syndrome coronavirus 2 Vero Cells Viral Plaque Assay - methods virology virus Virus Inactivation Viruses United States > US China coronavirus SARS-CoV-2 virology virus plaque assay inactivation
ISSN:	1999-4915, 1999-4915
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!